INBXInhibrx Biosciences, Inc.

$93.22+155% 1Y

Is the business good?

How good a business is INBX?

Share count, year on year
+1.3%

Share count, year on year · shareholders own a smaller slice than a year ago

Operating margin by fiscal year
YearOperating margin
FY2023−12179%
FY2024−165724%
FY2025−10387%
Details›
Revenue, trailing twelve months
$0
Free cash flow, trailing twelve months
−$132M
Net income, trailing twelve months
−$138M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

On our screens:Most shorted stocks